AWS has named Variational AI one of nine companies in its Canada’s AI Innovators series — a spotlight on Canadian organisations using artificial intelligence to solve some of society’s hardest problems, from wildfire detection to microplastic pollution to drug discovery.
In the featured video, Co-Founder and CEO Handol Kim explains why drug discovery is overdue for reinvention. Today it takes 10–12 years and hundreds of millions of dollars to bring a single drug to approval, with roughly a 10% probability of success once a candidate reaches human trials. The deeper bottleneck, Handol argues, isn’t biology — it’s the slow, one-molecule-at-a-time process of early discovery itself.
Reimagining discovery as a generative problem
Variational AI’s core insight was that drug discovery could be approached the way modern AI generates images from text — except using the language of chemistry. Our Enki™ platform is built on a foundation model trained on virtually every published, approved, and patented drug, allowing it to generate novel molecules optimised simultaneously for potency, selectivity, safety, and other properties. By solving this multi-parameter problem up front, Enki addresses the failure modes that derail most programs in the clinic — and does so roughly 100x more efficiently than the status quo.
As Handol puts it, the goal is for Enki to become the default first step for any company developing a small molecule drug.
Security that enables enterprise collaboration
The video also covers how AWS underpins Variational AI’s ability to work with major pharma partners. Each partner is served through a dedicated Virtual Private Cloud, keeping their proprietary data strictly separated from our internal compute — the architecture that makes secure collaboration at scale possible, including with partners like Merck.
A Canadian vision for health sovereignty
Handol also makes the case for Canada’s opportunity in pharma: the country has world-class AI talent and research depth, yet no homegrown non-generic pharmaceutical company in the global top 100. Variational AI sees its work as part of changing that.
Watch the full interview above, or read the complete case study on the AWS website.